Janux Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Janux Therapeutics generated cash of -$50,575,000, which is less than the previous year. Cash used in financing activities reached the amount of $59,548,000 last year. Net change in cash is therefore -$32,221,000.
Cash Flow
| 2019 | -3.82M | 0 | 4M |
|---|---|---|---|
| 2020 | -4.36M | 0 | 11.52M |
| 2021 | -16.97M | -340.96M | 386.52M |
| 2022 | -42.92M | 58.26M | 500K |
| 2023 | -50.57M | -41.19M | 59.54M |
JANX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 52.24M | 36.39M | 7.81M | 658K | 486K |
Operating activities | |||||
Net income | -58.29M | -63.05M | -32.67M | -6.78M | -4.00M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.95M | 841K | 113K | 13K | 6K |
Stock-based compensation expense | 20.00M | 17.20M | 6.91M | 72K | 6K |
| Deferred income tax benefit | 20.00M | 17.20M | 6.91M | 72K | 6K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 8M | -8M | 0 |
Inventories | 0 | 0 | 831K | 375K | 0 |
Accounts payable | 277K | -294K | 2.13M | 14K | 4K |
Cash generated by operating activities | -50.57M | -42.92M | -16.97M | -4.36M | -3.82M |
Investing activities | |||||
Purchases Of Investments | -317.34M | -294.38M | -473.62M | 0 | 0 |
Investments In Property Plant And Equipment | -1.85M | -6.44M | -1.48M | 0 | 0 |
Acquisitions Net | 0 | -64.71M | 339.48M | 0 | 0 |
Cash generated by investing activities | -41.19M | 58.26M | -340.96M | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 56.53M | 500K | 204.16M | 9.02M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -2.5M | 4M |
Cash used in financing activities | 59.54M | 500K | 386.52M | 11.52M | 4M |
Net Change In Cash | -32.22M | 15.84M | 28.58M | 7.15M | 172K |
Cash at end of period | 20.02M | 52.24M | 36.39M | 7.81M | 658K |
| Data source | Data source | Data source |